Fiocruz

Fiocruz has completed the technology transfer for dolutegravir, the main antiretroviral used in HIV treatment by Brazil's SUS. Large-scale production now depends on ANVISA registration.

29 Mwezi wa nne, 2026 Imeripotiwa na AI

Most Brazilian states report severe acute respiratory syndrome (SRAG) at alert, risk, or high-risk levels, according to Fiocruz's InfoGripe bulletin released on April 29. Cases are driven mainly by influenza A and respiratory syncytial virus (RSV), which circulate more in autumn and winter. Exceptions are Rio de Janeiro, São Paulo, and Rio Grande do Sul.